Cindy Cooper

Has grant

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Efficacy and mechanism evaluation of transcutaneous vagal nerve stimulation for upper limb recovery post-stroke a randomised, controlled, multi-arm, multi-stage, adaptive design trial

Open Date: 2022-02-01

Close Date:

Grant: Close

Programme and Trial- Supporting Physical and Activity through Co-Production in People with Severe Mental Illness (SPACES

Open Date: 2021-06-01

Close Date: 2025-06-01

Grant: Close

Learning from COVID-19 related trial adaptations to inform efficient trial design - a sequential mixed methods study

Open Date: 2020-10-01

Close Date: 2021-10-01

Grant: Close

Double blinded placebo control study of Mesenchymal Intravenous Stromal cell Infusions in children with recessive dystrophic Epidermolysis Bullosa (MissionEB)

Open Date: 2020-08-01

Close Date: 2025-02-01

Grant: Close

Autologous Stem cell Transplantation versus Alemtuzumab in relapsing remitting MS

Open Date: 2019-01-01

Close Date: 2025-06-01

Articles (13)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

satyan Rajbhandari

Consultant Physician & Honorary Clinical Professor

UNITED KINGDOM

Cindy Cooper

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (13)

Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme

Identifying the Active Ingredients of a Computerized Speech and Language Therapy Intervention for Poststroke Aphasia: Multiple Methods Investigation Alongside a Randomized Controlled Trial

Play brick therapy to aid the social skills of children and young people with autism spectrum disorder: the I-SOCIALISE cluster RCT

One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT

Cost-utility analysis of LEGO based therapy for school children and young people with autism spectrum disorder: Results from a randomised controlled trial

An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT

A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.

Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT

Adjusting for bias in the mean for primary and secondary outcomes when trials are in sequence

One session treatment (OST) is equivalent to multi-session cognitive behavioral therapy (CBT) in children with specific phobias (ASPECT): results from a national non-inferiority randomized controlled trial.

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT): results from a randomised controlled trial

Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study

Collaborators (17)

satyan Rajbhandari

David Marshall

Christopher Sutton

Steven Julious

Matthew Bursnall

Uazman Alam

Charlotte Rawlinson

Adwoa Parker

Marion Dawn Teare

Alan Montgomery

Penny Bee

Lina Gega

Christopher Graham

Tom Dening

Stephen Walters

Tim Chater

Alexander Scott

Make your next move.